share_log

China Everbright (HKG:165) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 5.9% this past week

China Everbright (HKG:165) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 5.9% this past week

中國光大(HKG:165)的盈利和股東回報在過去五年中一直呈下降趨勢,但該股在過去一週上漲了5.9%
Simply Wall St ·  2022/06/01 21:51

The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results between individual stocks. So we wouldn't blame long term China Everbright Limited (HKG:165) shareholders for doubting their decision to hold, with the stock down 58% over a half decade. Shareholders have had an even rougher run lately, with the share price down 11% in the last 90 days. However, one could argue that the price has been influenced by the general market, which is down 5.2% in the same timeframe.

選股的主要目的是尋找跑贏大盤的股票。但在任何投資組合中,個股之間的結果都會喜憂參半。所以我們不會責怪長期中國光大股份有限公司(HKG:165)股東對他們持有股票的決定表示懷疑,該股在過去五年中下跌了58%。股東們最近的表現更加艱難,股價在過去90天裏下跌了11%。然而,有人可能會辯稱,價格受到了大盤的影響,大盤在同一時間段內下跌了5.2%。

On a more encouraging note the company has added HK$708m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

更令人鼓舞的是,僅在過去的7天裏,該公司的市值就增加了7.08億港元,所以讓我們看看我們是否能確定是什麼導致了股東五年來的虧損。

View our latest analysis for China Everbright

查看我們對中國光大的最新分析

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

在他的文章中格雷厄姆和多德斯維爾的超級投資者沃倫·巴菲特描述了股價並不總是理性地反映一家企業的價值。一種不完美但簡單的方法來考慮市場對一家公司的看法是如何改變的,那就是將每股收益(EPS)的變化與股價走勢進行比較。

During the five years over which the share price declined, China Everbright's earnings per share (EPS) dropped by 8.4% each year. Readers should note that the share price has fallen faster than the EPS, at a rate of 16% per year, over the period. This implies that the market is more cautious about the business these days. The less favorable sentiment is reflected in its current P/E ratio of 4.91.

在股價下跌的五年中,中國光大的每股收益(EPS)每年下降8.4%。讀者應該注意到,在此期間,該公司股價以每年16%的速度下跌,速度比每股收益更快。這暗示這幾天市場對該業務更為謹慎。這種不那麼有利的情緒反映在其目前4.91的市盈率上。

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

下圖顯示了EPS是如何隨着時間的推移進行跟蹤的(如果您點擊該圖像,您可以看到更多詳細信息)。

SEHK:165 Earnings Per Share Growth June 2nd 2022
聯交所:165每股盈利增長2022年6月2日

We know that China Everbright has improved its bottom line lately, but is it going to grow revenue? Check if analysts think China Everbright will grow revenue in the future.

我們知道中國光大最近提高了利潤,但它會增加收入嗎?如果分析師認為中國光大未來營收將增長,請核對一下。

What About Dividends?

那股息呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for China Everbright the TSR over the last 5 years was -45%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

除了衡量股價回報外,投資者還應考慮總股東回報(TSR)。TSR是一種回報計算,計入了現金股息的價值(假設收到的任何股息都進行了再投資),以及任何貼現融資和剝離的計算價值。因此,對於支付豐厚股息的公司來説,TSR往往比股價回報高得多。我們注意到,中國光大過去5年的TSR為-45%,好於上面提到的股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的視角

Although it hurts that China Everbright returned a loss of 14% in the last twelve months, the broader market was actually worse, returning a loss of 22%. Unfortunately, last year's performance may indicate unresolved challenges, given that it's worse than the annualised loss of 8% over the last half decade. While some investors do well specializing in buying companies that are struggling (but nonetheless undervalued), don't forget that Buffett said that 'turnarounds seldom turn'. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that China Everbright is showing 2 warning signs in our investment analysis , and 1 of those makes us a bit uncomfortable...

儘管中國光大在過去12個月中虧損14%令人痛心,但大盤實際上更糟糕,虧損22%。不幸的是,去年的表現可能預示着尚未解決的挑戰,因為它比過去五年8%的年化損失更糟糕。雖然一些投資者擅長買入那些陷入困境(但估值仍然被低估)的公司,但不要忘記巴菲特曾説過,扭虧為盈的情況很少出現轉機。我發現,把股價作為衡量企業業績的長期指標是非常有趣的。但為了真正獲得洞察力,我們還需要考慮其他信息。即便如此,請注意,中國光大正在展示我們的投資分析中的2個警告信號,其中一條讓我們有點不舒服...

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

對於那些想要找到贏得投資免費最近有內幕收購的不斷增長的公司名單可能就是合適的選擇。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on HK exchanges.

請注意,本文引用的市場回報反映了目前在香港交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論